Semaglutide vs Tirzepatide: The Complete Comparison
An evidence-based analysis of the two leading GLP-1 medications for weight loss and metabolic health, including efficacy, side effects, dosing, and real-world costs.
Semaglutide
Ozempic • Wegovy • Rybelsus
Head-to-Head Comparison
Detailed breakdown of how Semaglutide and Tirzepatide compare across key factors.
| Factor | Semaglutide | Tirzepatide |
|---|---|---|
| Average Weight Loss | 15-17% | 20-22% ✓ |
| Maximum Weight Loss | ~20% | ~25% ✓ |
| Mechanism | GLP-1 receptor agonist | Dual GIP + GLP-1 receptor agonist |
| Starting Dose | 0.25mg weekly | 2.5mg weekly |
| Maintenance Dose | 1.0-2.4mg weekly | 5-15mg weekly |
| Nausea Rate | 44% | 31% ✓ |
| Brand Cost | $900-$1,500/month | $1,000-$1,200/month |
| Compounded Cost | $299-$499/month ✓ | $350-$550/month |
| Oral Option | Yes (Rybelsus) ✓ | No |
| Clinical Data | More extensive ✓ | Newer, growing |
Average Weight Loss
Semaglutide
15-17%
Tirzepatide
20-22%
Nausea Rate
Semaglutide
44%
Tirzepatide
31%
Brand Cost/Month
Semaglutide
$900-$1,500/month
Tirzepatide
$1,000-$1,200/month
Oral Option
Semaglutide
Yes
Tirzepatide
No
Side Effects Comparison
Both medications share similar GI-related side effects that typically improve over time.
Semaglutide Side Effects
Common (>10%)
- Nausea (44%)
- Diarrhea (30%)
- Vomiting (24%)
- Constipation (24%)
- Abdominal pain (20%)
Rare
- Pancreatitis (<1%)
- Gallbladder issues
- Thyroid C-cell tumors (animal studies)
Tirzepatide Side Effects
Common (>10%)
- Nausea (31%)
- Diarrhea (23%)
- Vomiting (12%)
- Constipation (12%)
- Decreased appetite
Rare
- Pancreatitis (<1%)
- Gallbladder issues
- Injection site reactions
Pros & Cons
Semaglutide
Pros
- Most clinical data available
- FDA approved for both diabetes and weight loss
- Proven cardiovascular benefits
- Oral option available (Rybelsus)
Cons
- Significant GI side effects initially
- Very expensive without insurance
- Muscle loss concerns without exercise
Tirzepatide
Pros
- Superior weight loss results
- Dual mechanism may preserve muscle better
- Slightly lower GI side effect rates
- Better blood sugar control
Cons
- Newer with less long-term data
- Expensive without insurance
- No oral option yet
Frequently Asked Questions
Which is better for weight loss: Semaglutide or Tirzepatide?
Clinical trials show Tirzepatide produces greater average weight loss (20-22%) compared to Semaglutide (15-17%). However, individual results vary and the 'better' option depends on your specific health profile, insurance coverage, and how you tolerate each medication.
Can I switch from Semaglutide to Tirzepatide?
Yes, many patients switch between medications under physician guidance. If you've plateaued on Semaglutide or experienced intolerable side effects, your doctor may recommend trying Tirzepatide. There's typically a washout period of 1-2 weeks when switching.
How long do I need to take GLP-1 medications?
Current evidence suggests GLP-1 medications work best as long-term therapy. Studies show significant weight regain (up to 2/3 of lost weight) within 1-2 years of stopping. Your physician will help determine the appropriate duration based on your goals.
Will I lose muscle on GLP-1 medications?
Rapid weight loss from any source can lead to muscle loss. Studies show 25-40% of weight lost on GLP-1s may be lean mass. Combining treatment with resistance training and adequate protein intake (0.8-1g per pound bodyweight) helps preserve muscle.
Are compounded versions safe?
Compounded GLP-1 medications from licensed 503B compounding pharmacies can be a more affordable option. However, quality varies between pharmacies. Ensure your provider uses a reputable, FDA-registered compounding pharmacy with third-party testing.